Yajuan Zhang

Targets

• EGFR 2

Filled chips are declared by the researcher; the others come from publications (number of works).

Now

Trials, publications and grants since Nov 2024.

• Publication

  An alternative EGFR activation by patient-derived R252C mutation promotes cancer progression.

  Nature communications, Jan 2026

• Publication

  YTHDC2 inhibits the resistance of lung cancer to EGFR-TKI through cuproptosis.

  Oncogene, Dec 2025

• Publication

  Compression-induced NF-κB activation sustains tumor cell survival in confinement by detoxifying aldehydes and promotes metastasis.

  Nature communications, Dec 2025

Affiliations

• Shanghai Chest Hospital
• Shanghai Jiao Tong University
• University of Chinese Academy of Sciences
• Chinese Academy of Sciences

Co-authors

Who links you

Enter another researcher's profile link or ID to see who has published with both of you.